US Stock MarketDetailed Quotes
NIKA NIKA PHARMACEUTICALS INC
- 0.507
- 0.0000.00%
15min DelayClose Nov 22 16:00 ET
516.61MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.507Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)1.02BShares0.75052wk High0.00P/B516.61MFloat Cap0.14352wk Low--Dividend TTM1.02BShs Float0.750Historical High--Div YieldTTM0.00%Amplitude0.143Historical Low--Avg Price1Lot Size
NIKA PHARMACEUTICALS INC Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --156 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -17.51%8.37K | 97.64%54.96K | 237.19%65.99K | -97.96%64.83K | -51.40%7.31K | 60.01%10.14K | -99.12%27.81K | 209.85%19.57K | 21,540.26%3.18M | 356.06%15.05K |
| Selling and administrative expenses | -17.51%8.37K | 97.64%54.96K | 237.19%65.99K | -64.71%64.83K | -51.40%7.31K | 60.01%10.14K | -82.18%27.81K | 209.85%19.57K | 1,148.74%183.72K | 356.06%15.05K |
| -General and administrative expense | -17.51%8.37K | 97.64%54.96K | 237.19%65.99K | -64.71%64.83K | -51.40%7.31K | 60.01%10.14K | -82.18%27.81K | 209.85%19.57K | 1,148.74%183.72K | 356.06%15.05K |
| Research and development costs | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3M | --0 |
| Operating profit | 17.51%-8.37K | -97.08%-54.8K | -237.19%-65.99K | 97.96%-64.83K | 51.40%-7.31K | -60.01%-10.14K | 99.12%-27.81K | -209.85%-19.57K | -21,540.26%-3.18M | -356.06%-15.05K |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | ||||||||||
| Income before tax | 17.51%-8.37K | -97.08%-54.8K | -237.19%-65.99K | 97.96%-64.83K | 51.40%-7.31K | -60.01%-10.14K | 99.12%-27.81K | -209.85%-19.57K | -21,540.26%-3.18M | -356.06%-15.05K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 17.51%-8.37K | -97.08%-54.8K | -237.19%-65.99K | 97.96%-64.83K | 51.40%-7.31K | -60.01%-10.14K | 99.12%-27.81K | -209.85%-19.57K | -21,540.26%-3.18M | -356.06%-15.05K |
| Net income continuous Operations | 17.51%-8.37K | -97.08%-54.8K | -237.19%-65.99K | 97.96%-64.83K | 51.40%-7.31K | -60.01%-10.14K | 99.12%-27.81K | -209.85%-19.57K | -21,540.26%-3.18M | -356.06%-15.05K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 17.51%-8.37K | -97.08%-54.8K | -237.19%-65.99K | 97.96%-64.83K | 51.40%-7.31K | -60.01%-10.14K | 99.12%-27.81K | -209.85%-19.57K | -21,540.26%-3.18M | -356.06%-15.05K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 17.51%-8.37K | -97.08%-54.8K | -237.19%-65.99K | 97.96%-64.83K | 51.40%-7.31K | -60.01%-10.14K | 99.12%-27.81K | -209.85%-19.57K | -21,540.26%-3.18M | -356.06%-15.05K |
| Basic earnings per share | 33.33%-0 | -68.75%-0.0001 | -240.91%-0.0001 | 97.96%-0.0001 | 52.94%-0 | -71.43%-0 | 99.11%-0 | -214.29%-0 | -21,276.47%-0.0036 | -325.00%-0 |
| Diluted earnings per share | 33.33%-0 | -68.75%-0.0001 | -240.91%-0.0001 | 97.96%-0.0001 | 52.94%-0 | -71.43%-0 | 99.11%-0 | -214.29%-0 | -21,276.47%-0.0036 | -325.00%-0 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data